Total Payments
$10,817
2024 Payments
$126.61
Companies
29
Transactions
159
Medicare Patients
3,323
Medicare Billing
$232,024
Payment Breakdown by Category
Other$5,237 (48.4%)
Food & Beverage$2,807 (26.0%)
Consulting$1,395 (12.9%)
Travel$1,264 (11.7%)
Education$114.52 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Current or prospective ownership or investment interest | $5,237 | 2 | 48.4% |
| Food and Beverage | $2,807 | 147 | 26.0% |
| Consulting Fee | $1,395 | 1 | 12.9% |
| Travel and Lodging | $1,264 | 2 | 11.7% |
| Education | $114.52 | 2 | 1.1% |
| Unspecified | $0 | 5 | 0.0% |
Payments by Type
General
$10,817
154 transactions
Ownership
$0
5 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Innovative Medical Technologies, LLC | $5,237 | 7 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $1,615 | 10 | $0 (2023) |
| NeoTract Inc. | $1,404 | 4 | $0 (2018) |
| Astellas Pharma US Inc | $774.78 | 51 | $0 (2024) |
| Cook Incorporated | $309.08 | 4 | $0 (2017) |
| PFIZER INC. | $278.50 | 18 | $0 (2020) |
| Bayer HealthCare Pharmaceuticals Inc. | $127.92 | 7 | $0 (2019) |
| Ferring Pharmaceuticals Inc. | $124.05 | 7 | $0 (2019) |
| MEDIVATION INC. | $118.37 | 7 | $0 (2017) |
| Olympus America Inc. | $106.24 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $126.61 | 7 | Astellas Pharma US Inc ($50.96) |
| 2023 | $332.46 | 12 | AstraZeneca Pharmaceuticals LP ($95.12) |
| 2022 | $55.31 | 3 | AstraZeneca Pharmaceuticals LP ($22.94) |
| 2021 | $1,818 | 26 | AstraZeneca Pharmaceuticals LP ($1,497) |
| 2020 | $76.98 | 6 | Merck Sharp & Dohme Corporation ($31.27) |
| 2019 | $271.39 | 16 | Astellas Pharma US Inc ($64.53) |
| 2018 | $1,792 | 34 | NeoTract Inc. ($1,404) |
| 2017 | $6,345 | 55 | Innovative Medical Technologies, LLC ($5,237) |
All Payment Transactions
159 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: Diabetes Care | ||||||
| 10/29/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Oncology | ||||||
| 07/21/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Oncology | ||||||
| 06/17/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/18/2024 | ConvaTec Inc. | INNOVAMATRIX AC (Device) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 03/12/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: Oncology | ||||||
| 02/05/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Bone Health | ||||||
| 12/18/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Bone Health | ||||||
| 12/13/2023 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Oncology | ||||||
| 10/07/2023 | Olympus America Inc. | Soltive (Device) | Food and Beverage | In-kind items and services | $41.60 | General |
| Category: Urology Gynecology | ||||||
| 09/06/2023 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $25.59 | General |
| Category: Oncology | ||||||
| 08/30/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: Biological | ||||||
| 06/02/2023 | Olympus America Inc. | Olympus (Device) | Food and Beverage | In-kind items and services | $37.78 | General |
| Category: Urology Gynecology | ||||||
| 05/11/2023 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $76.04 | General |
| Category: Oncology | ||||||
| 03/01/2023 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Oncology | ||||||
| 02/24/2023 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: ONCOLOGY | ||||||
| 02/04/2023 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: Oncology | ||||||
| 01/22/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: Diabetes Care | ||||||
| 01/19/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Diabetes | ||||||
| 12/01/2022 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: Oncology | ||||||
| 11/16/2022 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: Oncology | ||||||
| 08/18/2022 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Urology Gynecology | ||||||
| 12/17/2021 | Myovant Sciences Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: HORMONE THERAPY | ||||||
| 11/16/2021 | Blue Earth Diagnostics Limited | Axumin (Drug) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: Diagnostic Imaging | ||||||
| 11/05/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 480 | 557 | $70,314 | $25,461 |
| 2022 | 10 | 509 | 574 | $127,942 | $32,671 |
| 2021 | 18 | 1,725 | 9,744 | $531,690 | $144,156 |
| 2020 | 13 | 609 | 681 | $128,018 | $29,736 |
Total Patients
3,323
Total Services
11,556
Medicare Billing
$232,024
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 103 | 130 | $29,211 | $10,461 | 35.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 39 | 42 | $11,080 | $5,304 | 47.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 38 | 38 | $12,043 | $3,984 | 33.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 15 | 15 | $5,178 | $2,329 | 45.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 42 | 48 | $7,559 | $2,068 | 27.4% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 88 | 99 | $2,671 | $699.54 | 26.2% |
| 81002 | Urinalysis, manual test | Office | 2023 | 89 | 106 | $743.88 | $361.46 | 48.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 55 | 66 | $1,578 | $145.20 | 9.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 11 | 13 | $250.00 | $109.20 | 43.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 102 | 115 | $42,775 | $10,736 | 25.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 96 | 122 | $32,291 | $8,178 | 25.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 50 | 50 | $24,800 | $6,508 | 26.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 13 | 13 | $8,395 | $2,265 | 27.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 25 | 25 | $8,275 | $2,031 | 24.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 13 | $6,929 | $1,811 | 26.1% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 83 | 92 | $2,950 | $702.25 | 23.8% |
| 81002 | Urinalysis, manual test | Office | 2022 | 62 | 66 | $757.96 | $226.18 | 29.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 48 | 57 | $580.00 | $167.64 | 28.9% |
| 81003 | Automated urinalysis test | Office | 2022 | 19 | 21 | $189.00 | $46.26 | 24.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 296 | 523 | $144,871 | $47,201 | 32.6% |
| J9155 | Injection, degarelix, 1 mg | Office | 2021 | 14 | 6,962 | $76,582 | $22,398 | 29.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 110 | 165 | $61,215 | $20,781 | 33.9% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2021 | 62 | 78 | $51,246 | $12,491 | 24.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 127 | 177 | $33,099 | $9,786 | 29.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 41 | 41 | $21,935 | $5,997 | 27.3% |
About Dr. Thomas Patterson, MD
Dr. Thomas Patterson, MD is a Urology healthcare provider based in Galesburg, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1568460970.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Patterson, MD has received a total of $10,817 in payments from pharmaceutical and medical device companies, with $126.61 received in 2024. These payments were reported across 159 transactions from 29 companies. The most common payment nature is "Current or prospective ownership or investment interest" ($5,237).
As a Medicare-enrolled provider, Patterson has provided services to 3,323 Medicare beneficiaries, totaling 11,556 services with total Medicare billing of $232,024. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Galesburg, IL
- Active Since 07/09/2005
- Last Updated 11/29/2012
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1568460970
Products in Payments
- LYNPARZA (Drug) $1,615
- UroLift (Device) $1,404
- XTANDI (Drug) $654.18
- Cook Medical Urology (Device) $283.77
- Xtandi (Drug) $185.25
- Xofigo (Drug) $127.92
- Myrbetriq (Drug) $118.63
- FIRMAGON (Drug) $88.22
- ZYTIGA (Drug) $73.19
- KEYTRUDA (Biological) $65.21
- MYRBETRIQ (Drug) $62.28
- OPDIVO (Biological) $55.56
- Prolia (Biological) $53.86
- XIAFLEX (Biological) $52.23
- FREESTYLE LIBRE 3 (Device) $46.18
- Soltive (Device) $41.60
- Olympus (Device) $37.78
- EVENITY (Biological) $35.59
- TOVIAZ (Drug) $34.08
- PREMARIN ORALS (Drug) $28.72
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.